DHR
DANAHER CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$211.77
−0.34%Margins
Gross margin
58.5%
EBITDA margin
28.5%
EBIT margin
20.4%
Net margin
15.9%
FCF margin
21.8%
7.6%
Return on equity
4.3%
Return on assets
6.5%
Return on invested capital
0.29x
Asset turnover
$6.6B
Cash from operations
$6.19
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026